1. Home
  2. MTDR vs BLCO Comparison

MTDR vs BLCO Comparison

Compare MTDR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MTDR

Matador Resources Company

HOLD

Current Price

$41.24

Market Cap

5.4B

Sector

Energy

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.15

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTDR
BLCO
Founded
2003
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Oil & Gas Production
Ophthalmic Goods
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
MTDR
BLCO
Price
$41.24
$17.15
Analyst Decision
Buy
Hold
Analyst Count
15
14
Target Price
$61.71
$17.31
AVG Volume (30 Days)
1.4M
352.7K
Earning Date
02-17-2026
02-18-2026
Dividend Yield
3.62%
N/A
EPS Growth
N/A
N/A
EPS
6.24
N/A
Revenue
$3,556,751,000.00
$4,976,000,000.00
Revenue This Year
$14.67
$8.06
Revenue Next Year
N/A
$5.79
P/E Ratio
$6.63
N/A
Revenue Growth
14.75
6.23
52 Week Low
$35.19
$10.45
52 Week High
$64.05
$18.34

Technical Indicators

Market Signals
Indicator
MTDR
BLCO
Relative Strength Index (RSI) 44.62 58.18
Support Level $40.50 $16.22
Resistance Level $44.20 $17.26
Average True Range (ATR) 1.28 0.34
MACD -0.13 -0.06
Stochastic Oscillator 20.00 83.97

Price Performance

Historical Comparison
MTDR
BLCO

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: